Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schulz

Showing results (791-800 of 835) with videos related to

Pageof 84
Sort By:
Antimicrobial Agents and Chemotherapy|November 8, 2022
Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle StagesSvenja M Sake, Christina Kosch, Sebastian Blockus, et al.
BMJ (Clinical Research Ed.)|March 25, 2025
Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled TrialsYing Wang, Sheri Keitz, Matthias Briel, et al.
Journal of Medical Virology|August 16, 2001
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assaysO Schatz, P Monini, R Bugarini, et al.
Annals of Internal Medicine|September 5, 2012
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trialsJelena Savović, Hayley E Jones, Douglas G Altman, et al.
Nature Communications|May 7, 2024
A comprehensive genetic map of cytokine responses in Lyme borreliosisJavier Botey-Bataller, Hedwig D Vrijmoeth, Jeanine Ursinus, et al.
Annals of Internal Medicine|January 9, 2013
SPIRIT 2013 statement: defining standard protocol items for clinical trialsAn-Wen Chan, Jennifer M Tetzlaff, Douglas G Altman, et al.
Cellular & Molecular Immunology|November 3, 2020
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methodsBerislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|July 22, 2016
SPIRIT 2013 Statement: defining standard protocol items for clinical trialsAn-Wen Chan, Jennifer M Tetzlaff, Douglas G Altman, et al.
Molecular Psychiatry|September 4, 2013
Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrityC Hammer, B Stepniak, A Schneider, et al.
The Journal of Infectious Diseases|May 4, 2019
Human Cytomegalovirus Genomes Sequenced Directly From Clinical Material: Variation, Multiple-Strain Infection, Recombination, and Gene LossNicolás M Suárez, Gavin S Wilkie, Elias Hage, et al.
Pageof 84

Showing results (791-800 of 835) with videos related to

Sort By:
Pageof 84
Antimicrobial Agents and Chemotherapy|November 8, 2022
Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle StagesSvenja M Sake, Christina Kosch, Sebastian Blockus, et al.
BMJ (Clinical Research Ed.)|March 25, 2025
Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled TrialsYing Wang, Sheri Keitz, Matthias Briel, et al.
Journal of Medical Virology|August 16, 2001
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assaysO Schatz, P Monini, R Bugarini, et al.
Annals of Internal Medicine|September 5, 2012
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trialsJelena Savović, Hayley E Jones, Douglas G Altman, et al.
Nature Communications|May 7, 2024
A comprehensive genetic map of cytokine responses in Lyme borreliosisJavier Botey-Bataller, Hedwig D Vrijmoeth, Jeanine Ursinus, et al.
Annals of Internal Medicine|January 9, 2013
SPIRIT 2013 statement: defining standard protocol items for clinical trialsAn-Wen Chan, Jennifer M Tetzlaff, Douglas G Altman, et al.
Cellular & Molecular Immunology|November 3, 2020
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methodsBerislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|July 22, 2016
SPIRIT 2013 Statement: defining standard protocol items for clinical trialsAn-Wen Chan, Jennifer M Tetzlaff, Douglas G Altman, et al.
Molecular Psychiatry|September 4, 2013
Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrityC Hammer, B Stepniak, A Schneider, et al.
The Journal of Infectious Diseases|May 4, 2019
Human Cytomegalovirus Genomes Sequenced Directly From Clinical Material: Variation, Multiple-Strain Infection, Recombination, and Gene LossNicolás M Suárez, Gavin S Wilkie, Elias Hage, et al.
Pageof 84